0001209191-16-133709.txt : 20160722 0001209191-16-133709.hdr.sgml : 20160722 20160722161356 ACCESSION NUMBER: 0001209191-16-133709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160719 FILED AS OF DATE: 20160722 DATE AS OF CHANGE: 20160722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shak Steven CENTRAL INDEX KEY: 0001337334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 161779851 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-19 0 0001131324 GENOMIC HEALTH INC GHDX 0001337334 Shak Steven 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Scientific Officer Common Stock 2016-07-19 4 M 0 5000 18.89 A 332207 D Common Stock 2016-07-19 4 S 0 5000 27.4221 D 327207 D Employee Stock Option (right to buy) 18.89 2016-07-19 4 M 0 5000 0.00 D 2016-11-30 Common Stock 5000 20000 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2016. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $27.24 to $27.62. Includes an aggregate of 15,764 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2016-07-22